FI924278A - Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner - Google Patents

Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner Download PDF

Info

Publication number
FI924278A
FI924278A FI924278A FI924278A FI924278A FI 924278 A FI924278 A FI 924278A FI 924278 A FI924278 A FI 924278A FI 924278 A FI924278 A FI 924278A FI 924278 A FI924278 A FI 924278A
Authority
FI
Finland
Prior art keywords
bcrf1
virusinfektioner
skoetsel
antagonister
foer
Prior art date
Application number
FI924278A
Other languages
English (en)
Other versions
FI924278A0 (fi
Inventor
Kevin W Moore
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI924278A publication Critical patent/FI924278A/fi
Publication of FI924278A0 publication Critical patent/FI924278A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
FI924278A 1990-03-26 1992-09-24 Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner. FI924278A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49898590A 1990-03-26 1990-03-26
PCT/US1991/001812 WO1991014451A1 (en) 1990-03-26 1991-03-22 Bcrf1 antagonists for treating epstein-barr virus infections

Publications (2)

Publication Number Publication Date
FI924278A true FI924278A (fi) 1992-09-24
FI924278A0 FI924278A0 (fi) 1992-09-24

Family

ID=23983319

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924278A FI924278A0 (fi) 1990-03-26 1992-09-24 Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner.

Country Status (23)

Country Link
US (1) US5756342A (fi)
EP (1) EP0522010B1 (fi)
JP (1) JP2509774B2 (fi)
KR (1) KR960004856B1 (fi)
CN (1) CN1056245A (fi)
AT (1) ATE126704T1 (fi)
AU (1) AU650013B2 (fi)
CA (1) CA2079230C (fi)
DE (1) DE69112392T2 (fi)
DK (1) DK0522010T3 (fi)
ES (1) ES2076526T3 (fi)
FI (1) FI924278A0 (fi)
GR (1) GR3017920T3 (fi)
HU (1) HUT63339A (fi)
IE (1) IE70910B1 (fi)
IL (1) IL97629A0 (fi)
MX (1) MX9203522A (fi)
MY (1) MY106163A (fi)
NO (1) NO923749L (fi)
OA (1) OA09674A (fi)
PT (1) PT97108B (fi)
WO (1) WO1991014451A1 (fi)
ZA (1) ZA912138B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998010792A1 (en) * 1996-09-11 1998-03-19 Prendergast Patrick T Immune direction therapy
CN111574621B (zh) * 2020-04-30 2022-03-29 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种中和eb病毒的单克隆抗体及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614810A (en) * 1984-09-24 1986-09-30 Pennwalt Corporation 4,5-dihydro-4-oxo-2-[(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives thereof
US5231012A (en) * 1989-06-28 1993-07-27 Schering Corporation Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)

Also Published As

Publication number Publication date
IE70910B1 (en) 1997-01-15
OA09674A (en) 1993-05-15
HUT63339A (en) 1993-08-30
NO923749D0 (no) 1992-09-25
IE910942A1 (en) 1991-10-09
AU650013B2 (en) 1994-06-09
DK0522010T3 (da) 1996-01-15
US5756342A (en) 1998-05-26
WO1991014451A1 (en) 1991-10-03
AU7588291A (en) 1991-10-21
IL97629A0 (en) 1992-06-21
GR3017920T3 (en) 1996-01-31
EP0522010B1 (en) 1995-08-23
JPH05501116A (ja) 1993-03-04
ZA912138B (en) 1991-12-24
PT97108B (pt) 1998-10-30
ES2076526T3 (es) 1995-11-01
JP2509774B2 (ja) 1996-06-26
MY106163A (en) 1995-03-31
PT97108A (pt) 1991-11-29
KR960004856B1 (ko) 1996-04-16
NO923749L (no) 1992-09-25
CA2079230C (en) 2001-02-13
EP0522010A1 (en) 1993-01-13
ATE126704T1 (de) 1995-09-15
CA2079230A1 (en) 1991-09-27
CN1056245A (zh) 1991-11-20
DE69112392T2 (de) 1996-02-01
DE69112392D1 (de) 1995-09-28
MX9203522A (es) 1992-07-01
FI924278A0 (fi) 1992-09-24

Similar Documents

Publication Publication Date Title
MY107079A (en) Method of reducing immunoglobulin e responses
DK0504307T3 (da) Fremgangsmåde til behandling af septisk shock
DK81691D0 (da) Fremgangsmaade til forhindring eller reduktion af eosinofili
FI924278A (fi) Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.

Legal Events

Date Code Title Description
FD Application lapsed